Systems and methods for point of use water modification
US-12392115-B2 · Aug 19, 2025 · US
This page is not indexed by search engines while we improve data quality.
Wright Stephen patents
Wright Stephen is listed as an inventor on 112 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Wright Stephen |
| Total patents | 112 |
| First publication | Mar 26, 2015 |
| Latest publication | Aug 19, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Use of cannabidiolic acid in the treatment of autism spectrum disorder and associated disorders
US-12150927-B2 · Nov 26, 2024 · US
Use of cannabinoids in the treatment of epilepsy
US-12064399-B2 · Aug 20, 2024 · US
Use of cannabidiol in the treatment of nocturnal snoring
US-2024261234-A1 · Aug 8, 2024 · US
Use of cannabinoids in the treatment of epilepsy
US-2024165048-A1 · May 23, 2024 · US
Use of cannabinoids in the treatment of epilepsy
US-11963937-B2 · Apr 23, 2024 · US
Use of cannabinoids in the treatment of epilepsy
US-2024033229-A1 · Feb 1, 2024 · US
Use of cannabinoids in the treatment of epilepsy
US-2023301936-A1 · Sep 28, 2023 · US
Use of cannabinoids in the treatment of epilepsy
US-11766411-B2 · Sep 26, 2023 · US
Use of cannabidivarin in the treatment of autism spectrum disorder, associated disorders and schizophrenia
US-11752111-B2 · Sep 12, 2023 · US
Recent patents
Latest publications not already listed above.
Use of cannabinoids in the treatment of angelman syndrome
US-2023263744-A1 · Aug 24, 2023 · US
Use of cannabinoids in the treatment of epilepsy
US-2023248664-A1 · Aug 10, 2023 · US
Use of cannabinoids in the treatment of epilepsy
US-11701330-B2 · Jul 18, 2023 · US
Use of cannabinoids in the treatment of Angelman syndrome
US-11679087-B2 · Jun 20, 2023 · US
Use of cannabinoids in the treatment of epilepsy
US-11633369-B2 · Apr 25, 2023 · US
Use of cannabidiol in the treatment of nocturnal snoring
US-2023032502-A1 · Feb 2, 2023 · US
Use of cannabinoids in the treatment of epilepsy
US-2022395471-A1 · Dec 15, 2022 · US
Use of cannabinoids in the treatment of epilepsy
US-2022387348-A1 · Dec 8, 2022 · US
Use of cannabinoids in the treatment of epilepsy
US-2022378717-A1 · Dec 1, 2022 · US
Use of cannabidiol in the treatment of epilepsy
US-2022323375-A1 · Oct 13, 2022 · US
Systems and methods for point of use water modification
US-2022315447-A1 · Oct 6, 2022 · US
Systems and methods for point of use water modification
US-2022316191-A1 · Oct 6, 2022 · US
Use of cannabinoids in the treatment of epilepsy
US-11446258-B2 · Sep 20, 2022 · US
Oral cannabinoid formulations
US-11426362-B2 · Aug 30, 2022 · US
Use of cannabidiol in the treatment of epilepsy
US-11400055-B2 · Aug 2, 2022 · US
Cannabinoids in the treatment of epilepsy
US-2022202738-A1 · Jun 30, 2022 · US
Use of cannabinoids in the treatment of epilepsy
US-11357741-B2 · Jun 14, 2022 · US
Use of cannabinoids in the treatment of epilepsy
US-11311498-B2 · Apr 26, 2022 · US
Parenteral formulations
US-2022096397-A1 · Mar 31, 2022 · US
Parenteral formulations
US-11229612-B2 · Jan 25, 2022 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Gw Res Ltd | 66 |
| Gw Pharma Ltd | 42 |
| Otsuka Pharma Co Ltd | 7 |
| Wright Stephen | 3 |
| Procter & Gamble | 3 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61K31/658 | 108 |
| A61K31/05 | 106 |
| A61K36/185 | 96 |
| A61K45/06 | 90 |
| A61K31/352 | 84 |